ArticleBMC musculoskeletal disorders2025
Comparison of the therapeutic efficacy of leukocyte-poor and leukocyte-rich platelet-rich plasma in rabbit knee osteoarthritis and the study of autophagy mechanism.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Oleanolic acid cubic liquid crystal nanoparticle-based thermosensitive gel attenuates knee osteoarthritis symptoms in rats.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Osteoarthritis of the knee (KOA) is a degenerative disease characterized by the deterioration, destruction, and proliferation of articular cartilage and synovium. Autophagy, a crucial intracellular homeostatic mechanism, significantly contributes to the pathogenesis of OA. Platelet-rich plasma (PRP), derived from autologous blood, contains a high concentration of platelets that secrete various growth factors, promoting the regeneration and repair of joint structures. In this experiment, we compared leukocyte-rich platelet-rich plasma (LR-PRP) with leukocyte-poor platelet-rich plasma (LP-PRP) in a rabbit osteoarthritis model induced by papain to investigate the therapeutic efficacy and mechanism of action of platelet-rich plasma on osteoarthritis. Additionally, we analyzed whether different leukocyte concentrations in platelet-rich plasma would affect the treatment outcomes. Papain was injected into the knee joints of 32 rabbits to induce osteoarthritis, and the animals were cultured until bone maturity. LP-PRP and LR-PRP were prepared using different centrifugation methods and injected into the knee joint cavity. Eight weeks after the injection, various analyses were performed on the rabbit knee joint synovium and cartilage. These included HE staining, immunohistochemistry for PI3K, AKT, mTOR, LC3-II, MMP-13, toluidine blue staining, and ELISA for IL-1β and TNF-α in joint fluid. The synovial membrane was scored using the Krenn score, and cartilage was evaluated with the Mankin pathology score. Quantitative analysis of immunohistochemistry was conducted using ImageJ image processing software. The rabbit osteoarthritis model was successfully established by injecting papain into the knee joint cavity. All indices showed significant differences between the model group and the control group (P < 0.05). Both LP-PRP and LR-PRP exhibited therapeutic effects compared to the model group (P < 0.05). The concentrations of IL-1β and TNF-α in the LP-PRP group were significantly lower than those in the LR-PRP group (P < 0.05). However, no significant differences were observed in the morphology of the synovial membrane, cartilage, and other indices between the LR-PRP and LP-PRP groups (P > 0.05).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.